Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Astrazeneca Pharma India: Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Disclosure Of ESG Rating
News Announcement

Astrazeneca Pharma India: Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Disclosure Of ESG Rating

24-Aug-2026 Follow Value Research Online on Google download pdfDownload PDF Astrazeneca Pharma

Please find the enclosed intimation of the Company in relation to the captioned subject for reference.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan